Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Cash and Short-Term Investments

Arbutus Biopharma Cp Cash and Short-Term Investments Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Cash and Short-Term Investments from 2010 to 2018.
  • Arbutus Biopharma Cp Cash and Short-Term Investments for the quarter ending December 12, 2018 was $125m a -38.48% decrease of -48m year over year
  • Arbutus Biopharma Cp Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $125m a -38.48% decrease of -48m year over year
  • Arbutus Biopharma Cp Annual Cash and Short-Term Investments for 2018 was $125m a -1.44% decrease of -2m from 2017
  • Arbutus Biopharma Cp Annual Cash and Short-Term Investments for 2017 was $126m a -3.29% decrease of -4m from 2016
  • Arbutus Biopharma Cp Annual Cash and Short-Term Investments for 2016 was $131m a -38.87% decrease of -51m from 2015
Other Balance Sheet Metrics:
  • Arbutus Biopharma Cp Total Assets for the quarter ending December 12, 2018 was $228m a -18.48% decrease of -42m year over year
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Total Equity for the quarter ending December 12, 2018 was $200m a -16.09% decrease of -32m year over year
View Chart On Koyfin

Quarterly ABUS Cash and Short-Term Investments Data

12/2018$125m
09/2018$142m
06/2018$155m
03/2018$173m
12/2017$126m
09/2017$88m
06/2017$103m
03/2017$110m
12/2016$131m
09/2016$150m

Annual ABUS Cash and Short-Term Investments Data

2018$125m
2017$126m
2016$131m
2015$181m
2014$112m
2013$69m
2012$47m
2011$9m
2010$12m
2009$23m